Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

14. Avril 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2986


	Articles 1 - 20 / 59705

	The effect of LysaKare infusion on serum potassium levels in patients with gastroenteropancreatic neuroendocrine tumours eligible for treatment with [(177)Lu]Lu-DOTA-TATE: A post-authorisation safety study. J Neuroendocrinol Hofland J, Grana CM, Weickert MO, Moore AR, Shah T, Prakash V, Kolasi, de Herder WW, Spada F, Xu L, Fite R, Wu Y, . PMID: 41978231 [PubMed - indexed for MEDLINE]
	High Intratumoral PROS1 Expression Correlates with Improved Survival and Is Associated with Suppressed Oncogenic Signaling in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci Prouse T, Majumder R, Majumder S. PMID: 41977152 [PubMed - indexed for MEDLINE]
	Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer. Cancers (Basel) Kashima H, Kawai M, Iimori K, Nagao M, Morikawa TJ, Otomo R, Hirai M, Minaga K, Asada M, Umemura A, Uenoyama Y, Morita T, Yazumi S, Minami R, Marui S, Yamauchi Y, Nakai Y, Takada Y, Shio S, Yoshioka T, Kanda N, Masuda T, Nagai K, Hatano E, Fukuda A, Seno H. PMID: 41976399 [PubMed]
	Systematic Review and Meta-Analysis of Current and Novel Approaches in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer. Cancers (Basel) Le K, Le KDR, Hong W, Gibbs P, Yoshino O, Lee B. PMID: 41976359 [PubMed]
	Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer. Cancers (Basel) Zhang J, Geng M, Friess H, Demir IE, Scheufele F. PMID: 41976353 [PubMed]
	Cardiovascular Risk in Pancreatic Cancer: A Meta-Analysis of 197 Studies. Cancers (Basel) Németh J, Lee J, Eperjesi O, Gagyi EB, Bánfalvi Z, Lillik V, Creanga-Murariu I, Tóth R, Szalai EÁ, Obeidat M, Váncsa S, Bunduc S, Hegyi P. PMID: 41976330 [PubMed]
	Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights. Cancers (Basel) Yokoyama Y, Morimoto Y, Yamamoto H, Kouda S, Kawanami S, Yang R, Zhang Y, Tsujimoto M, Nagata N, Shimomura Y, Nishida K, Hata T, Inoue A, Shibata S, Yamamoto H, Mori M. PMID: 41976327 [PubMed]
	Pathogenesis, Diagnostic Pathways, and New Therapeutic and Nutritional Strategies for Pancreatic Cancer-Associated Cachexia. Cancers (Basel) Klus W, Ossowska J, Kowalcze K, Kiliszczyk A, Paziewska A. PMID: 41976282 [PubMed]
	EGFR ligand Angiogenin predicts response to ALK5 inhibition in pancreatic cancer via a TNF-Î± paracrine axis in tumor-associated macrophages. Oncogene Pietrobono S, De Vita V, Mangiameli D, Aparo A, Lorenzo ES, Bonato A, Bertolini M, Scarlato E, Casalino S, Quinzii A, Zecchetto C, Melisi D. PMID: 41975075 [PubMed - as supplied by publisher]
	Human endogenous retroviruses in liver cancer: a double-edged sword in tumor progression and anti-tumor immunity. Crit Rev Oncol Hematol Jiang X, Huang Z, Zhong Y, Lv W, Zhou R, Wang J, Liu J. PMID: 41974391 [PubMed - as supplied by publisher]
	Towards transparent and interpretable screening: multi-biofluid FTIR spectroscopy with LLM-Augmented explainability for pancreatic cancer detection. Methods Tang Z, Irvine O, Duckworth E, Costanzo C, Lillis K, Ren J, Anupama Bandaranayake PM, Sarireh BA, Mortimer M, Kanamarlapudi V, Higginbotham V, Chandrashekhara SH, Mora B, Roy D. PMID: 41974239 [PubMed - as supplied by publisher]
	Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation. Acta Oncol Søreide AH, Edland KH, Alvestad AB, Hodne S, Søreide K. PMID: 41972913 [PubMed - indexed for MEDLINE]
	Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective. Biology (Basel) Li X, Lyu H, Wu Y, Chen A, Wu G, Zhang R, Xiao S, Guo D, Zhang Q, Yan C, Tang J, Zhou C. PMID: 41972577 [PubMed]
	Immune Evasion of Helicobacter pylori and Extra-Gastric Cancer Risk. J Gastroenterol Hepatol Engin ED, Engin AB, Engin A. PMID: 41972361 [PubMed - as supplied by publisher]
	Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives. Front Immunol Zhang X, Tao X, Zhang Y, Gan G, Lv J, Zhang L, Dong D. PMID: 41972173 [PubMed - indexed for MEDLINE]
	mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting. Mol Cell Oncol Parganiha M, Rathored J, Sai Painkra D. PMID: 41971684 [PubMed]
	The development and validation of a machine learning algorithm for identifying lateral lymph nodes skip metastasis in papillary thyroid cancer. Front Oncol Cheng G, Zhang X, Cheng L, Ruan Y, Qiu Y. PMID: 41971436 [PubMed]
	Nourishing Hope: Five Essential Nutrition Tips for Patients With Pancreatic Cancer. J Adv Pract Oncol Hacker-Prietz A, Brown ME, Singer L, Narang A, Pathak P, Stricker C, Herman J. PMID: 41971144 [PubMed]
	Low-level HBV viremia independently predicts poor outcomes in patients with intermediate-to-advanced HBV-related hepatocellular carcinoma receiving systemic therapy: a multicenter retrospective study. Ther Adv Med Oncol Lei J, Ma H, Chen X, Lin L, Liang Z, Ou G, Jin J, Dai H, Zhang Y, Liu M, Li H, Lu Y. PMID: 41970939 [PubMed]
	Uncovered versus fully-covered self-expandable metal stents for nonpancreatic cancer: Propensity score-matched, multicenter study. Endosc Int Open Niiya F, Satoh T, Kaneko J, Ishikawa K, Tamai N, Yamawaki M, Noda J, Azami T, Takano Y, Nagahama M. PMID: 41970685 [PubMed]

Articles 1 - 20 / 59705

Page 1 de 2986



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité